Equity Rank covers 17 General Drug Manufacturers companies; 12 have a published model fair value, and 5 of those (42%) trade below the model estimate. The median model fair value sits 1.9% below the current price, under these model assumptions. Data as of 2026-10-22.
| Ticker | Company | Price | Model fair value | Gap |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1306.69 | $704.33 | -46.1% |
| JNJ | Johnson & Johnson | $267.61 | $223.28 | -16.6% |
| ABBV | AbbVie Inc | $284.88 | $231.45 | -18.8% |
| MRK | Merck & Company Inc | $147.30 | $141.91 | -3.7% |
| NVS | Novartis AG ADR | $156.27 | $162.77 | +4.2% |
| AZN | AstraZeneca PLC | $172.57 | $184.89 | +7.1% |
| AMGN | Amgen Inc | $447.28 | $446.49 | -0.2% |
| GILD | Gilead Sciences Inc | $157.19 | $146.56 | -6.8% |
| NVO | Novo Nordisk A/S | $39.51 | Not published | — |
| PFE | Pfizer Inc | $30.32 | $31.40 | +3.6% |
| BMY | Bristol-Myers Squibb Company | $63.00 | $98.13 | +55.8% |
| GSK | GlaxoSmithKline PLC ADR | $51.21 | Not published | — |
| SNY | Sanofi ADR | $41.96 | Not published | — |
| BIIB | Biogen Inc | $253.84 | $220.75 | -13.0% |
| GRFS | Grifols SA ADR | $7.45 | Not published | — |
| OGN | Organon & Co | $13.75 | $18.14 | +31.9% |
| AMRN | Amarin Corporation PLC | $11.60 | Not published | — |
LLY vs JNJ · LLY vs ABBV · LLY vs MRK · LLY vs NVS · LLY vs AZN · JNJ vs ABBV · JNJ vs MRK · JNJ vs NVS · JNJ vs AZN · ABBV vs MRK · ABBV vs NVS · ABBV vs AZN · MRK vs NVS · MRK vs AZN · NVS vs AZN
All industries · Compare any two stocks · Intrinsic Value Calculator